Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
This study is ongoing, but not recruiting participants.
Study NCT00603356   Information provided by OSI Pharmaceuticals
First Received: December 26, 2007   Last Updated: May 21, 2009   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2009
  Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)